NCT02873832View on ClinicalTrials.gov

Efficacy of Heat-shock Protein (HSP) Inhibitors in Myeloproliferative Syndromes (MPS)

CompletedOBSERVATIONAL
Enrollment

37

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

April 30, 2016

Conditions
Myeloproliferative Syndrome
Interventions
BIOLOGICAL

Blood sample

OTHER

Flow cytometry

OTHER

western blot

Trial Locations (1)

21079

CHU Dijon Bourgogne, Dijon

All Listed Sponsors
lead

Centre Hospitalier Universitaire Dijon

OTHER

NCT02873832 - Efficacy of Heat-shock Protein (HSP) Inhibitors in Myeloproliferative Syndromes (MPS) | Biotech Hunter | Biotech Hunter